These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30545078)

  • 1. Spatiotemporal Gait Analysis and Lower Limb Functioning in Foot Dystonia Treated with Botulinum Toxin.
    Datta Gupta A; Tucker G; Koblar S; Visvanathan R; Cameron ID
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30545078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for foot dystonia in patients with Parkinson's disease having deep brain stimulation: A case series and a pilot study.
    Gupta AD; Visvanathan R
    J Rehabil Med; 2016 Jun; 48(6):559-62. PubMed ID: 27122065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Onabotulinum Toxin A on Gait in Parkinson's Disease Patients with Foot Dystonia.
    Huang P; Li YY; Park JE; Huang P; Xiao Q; Wang Y; Chen S; Chen SD; Liu J; Wu YW
    Can J Neurol Sci; 2022 Jan; 49(1):123-128. PubMed ID: 33685541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
    Datta Gupta A; Visvanathan R; Cameron I; Koblar SA; Howell S; Wilson D
    BMC Neurol; 2019 May; 19(1):96. PubMed ID: 31078139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles.
    Priori A; Berardelli A; Mercuri B; Manfredi M
    Brain; 1995 Jun; 118 ( Pt 3)():801-7. PubMed ID: 7600096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease-A Systematic Review.
    Jabbari B; Comtesse SM
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia.
    Müller J; Wenning GK; Wissel J; Seppi K; Poewe W
    J Neurol; 2002 Mar; 249(3):300-4. PubMed ID: 11993530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot.
    Cioni M; Esquenazi A; Hirai B
    Am J Phys Med Rehabil; 2006 Jul; 85(7):600-6. PubMed ID: 16788391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia.
    Buchman AS; Comella CL; Stebbins GT; Tanner CM; Goetz CG
    Clin Neuropharmacol; 1993 Jun; 16(3):205-10. PubMed ID: 8504437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study to investigate the combined use of Botulinum toxin type-a and ankle foot orthosis for the treatment of spastic foot in chronic hemiplegic patients.
    Pradon D; Hutin E; Khadir S; Taiar R; Genet F; Roche N
    Clin Biomech (Bristol, Avon); 2011 Oct; 26(8):867-72. PubMed ID: 21592635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of botulinum neurotoxin on spatio-temporal gait parameters of patients with chronic stroke: a prospective open-label study.
    Gastaldi L; Lisco G; Pastorelli S; Dimanico U
    Eur J Phys Rehabil Med; 2015 Oct; 51(5):609-18. PubMed ID: 25519765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle Selection for Focal Limb Dystonia.
    Karp BI; Alter K
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29286305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type B in the treatment of residual limb hyperhidrosis for lower limb amputees: a pilot study.
    Kern U; Kohl M; Seifert U; Schlereth T
    Am J Phys Med Rehabil; 2011 Apr; 90(4):321-9. PubMed ID: 21765248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-latency reflexes of hand muscles in idiopathic focal dystonia and their modification by botulinum toxin.
    Naumann M; Reiners K
    Brain; 1997 Mar; 120 ( Pt 3)():409-16. PubMed ID: 9126053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Lücke D; Malezic M; Bertelt C; Friedrich H; Gregoric M; Mauritz KH
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1321-4. PubMed ID: 7964805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin in the treatment of cerebral palsy.
    Denislic M; Meh D
    Neuropediatrics; 1995 Oct; 26(5):249-52. PubMed ID: 8552214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.